Morgan Stanley Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Endo International plc (ENDP) Tops Q1 EPS by 8c
May 1, 2014 6:49 AM EDTEndo International plc (NASDAQ: ENDP) reported Q1 EPS of $0.92, $0.08 better than the analyst estimate of $0.84. Revenue for the quarter came in at $595 million versus the consensus estimate of $608.86 million.
Endo International plc sees FY2014 EPS of $3.60-$3.85, versus the consensus of $3.55. Endo... More
